Denali Therapeutics Inc (DNLI)

73.68 +0.10  +0.14% NASDAQ Jun 16, 16:59 USD
View Full Chart
Price Chart
View All DNLI News


View All Events


Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
05/05/2021 Earnings Results Q1 2021 Earnings Results
02/25/2021 Earnings Results Q4 2020 Earnings Results
11/05/2020 Earnings Results Q3 2020 Earnings Results
08/07/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
BTEC Principal Healthcare Innovators ETF 1.11%
BFGFX Baron Focused Growth Retail 0.85%
XBI SPDR® S&P Biotech ETF 0.79%
SFYX SoFi Next 500 ETF 0.56%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.44%
PQSG PGIM QMA Strategic Alpha Sm-Cp Gr ETF 0.26%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.